// STATE LEGISLATION TRACKER

Texas SB 54: Relating to the regulation of the cultivation, manufacture, processing, distribution, sale, testing, transportation, del

⚖️ NEUTRAL for peptide users 👤 NONE user impact 📜 Status: Signed

State: Texas
Bill: SB 54
Session: 892
Filed: 2025-07-30
Read the bill: OpenStates →
Last reviewed: 2026-10-02

Plain-English Summary

Texas SB54 is an elections bill about voters whose residence address is not current and when certain address-change updates take effect. Based on the title and subjects, it has no direct relevance to compounded peptides, off-label prescribing, telehealth care, clinician scope, FDA 503A/503B compounding, controlled substances, or prescription monitoring.

Key Points

No peptide prescribing or compounding provisions are indicated
No change to telehealth access for peptide care is indicated
No naturopathic, NP, or clinician scope change is indicated
No controlled-substance or prescription-monitoring change is indicated

What to Watch For

Note This appears limited to Texas election administration and voter address procedures.

Note No peptide-specific compliance action is suggested from the listed title and subjects.

Note The bill was signed and has an effective date of December 4, 2025.

Where the Bill Stands

The bill completed legislative action, was signed by the governor on September 17, 2025, and takes effect December 4, 2025.

· Ed. Our analysis pulls public bill metadata from OpenStates and is enriched with research-model context. We don't quote bill text we haven't read directly. If this bill matters to your practice or treatment access, read the official source linked above before taking action. We're an educational research directory, not a legal or medical reference.

Bill page generated 2026-11-04 · enriched via codex gpt-5.5
Source: OpenStates v3 API · View official bill · ← back to all laws